24-01-2025, 00:40

Workplace Options Unveils Comprehensive & Compassionate Return-to-Work Program for Cancer Survivors

Notified -
Globe Newswire24-01-2025, 00:40
7-01-2025, 20:00

Hummingbird Bioscience Licenses Novel Antibodies to Immunome

Notified -
Globe Newswire7-01-2025, 20:00
9-11-2024, 02:51

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition
Globe Newswire9-11-2024, 02:51
9-07-2024, 07:00

Io Therapeutics, Inc., announces presentation of data on induction of tumor growth inhibiting anti-cancer immune responses in multiple types of cancers by a IRX5010, a novel retinoic acid nuclear receptor agonist compound
Globe Newswire9-07-2024, 07:00
14-06-2024, 19:03

ElmediX Plans Series A Round Based on Strong Signals in a Clinical Study for Pancreatic Cancer Patients at the University Hospital Antwerp (Belgium)
Globe Newswire14-06-2024, 19:03
13-05-2024, 16:30

Hummingbird Bioscience Presents New Preclinical Data Highlighting Next-Generation Antibody-Drug Conjugate Capabilities at PEGS Boston 2024
Globe Newswire13-05-2024, 16:30
25-10-2023, 18:33

Curium and PIUR IMAGING Announce Thyroid Imaging Partnership in Germany to Enable Tomographic 3D Ultrasound Solutions
Globe Newswire25-10-2023, 18:33
2-03-2023, 05:53

United in the Fight Against Colorectal Cancer

Colorectal cancer is projected to be the leading cause of cancer deaths among those ages 20-49 in the next seven years
Globe Newswire2-03-2023, 05:53
2-02-2023, 19:02

Revolution Medicines to Participate in Upcoming Investor

REDWOOD CITY, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage
Globe Newswire2-02-2023, 19:02